Israel Englander Prelude Therapeutics Inc Transaction History

Millennium Management LLC

$192 Billion
Q4 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Millennium Management LLC holds 462,555 shares of PRLD stock, worth $402,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares

462,555

Previous 160,524 188.15%

Holding current value

$402,422

Previous $332,000 76.81%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.8 - $2.04 $241,624 - $616,143	302,031 Added 188.15%	462,555 $587,000
Q3 2024 Nov 14, 2024	BUY	$2.07 - $6.37 $332,284 - $1.02 Million	160,524 New	160,524 $332,000
Q1 2024 May 15, 2024	BUY	$2.68 - $4.84 $13,089 - $23,638	4,884 Added 5.04%	101,850 $482,000
Q4 2023 Feb 14, 2024	SELL	$1.69 - $4.37 $70,180 - $181,472	-41,527 Reduced 29.98%	96,966 $414,000
Q2 2023 Aug 14, 2023	BUY	$4.45 - $8.12 $8,784 - $16,028	1,974 Added 1.45%	138,493 $623,000
Q1 2023 May 15, 2023	BUY	$4.58 - $7.34 $397,466 - $636,987	86,783 Added 174.49%	136,519 $778,000
Q4 2022 Feb 14, 2023	SELL	$4.61 - $8.5 $49,280 - $90,865	-10,690 Reduced 17.69%	49,736 $300,000
Q3 2022 Nov 14, 2022	SELL	$5.0 - $8.82 $152,555 - $269,107	-30,511 Reduced 33.55%	60,426 $399,000
Q2 2022 Aug 15, 2022	BUY	$4.0 - $7.55 $206,504 - $389,776	51,626 Added 131.33%	90,937 $475,000
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $2.79 Million - $5.35 Million	-404,800 Reduced 91.15%	39,311 $271,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $31.74 $4.79 Million - $12.8 Million	403,260 Added 987.15%	444,111 $5.53 Million
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $512,841 - $768,864	19,893 Added 94.92%	40,851 $1.28 Million
Q2 2021 Aug 16, 2021	BUY	$28.63 - $44.3 $213,436 - $330,256	7,455 Added 55.21%	20,958 $600,000
Q1 2021 May 17, 2021	BUY	$39.27 - $91.68 $530,262 - $1.24 Million	13,503 New	13,503 $585,000
Q4 2020 Feb 16, 2021	SELL	$28.81 - $88.94 $5.46 Million - $16.9 Million	-189,573 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$26.2 - $30.13 $4.97 Million - $5.71 Million	189,573 New	189,573 $5.71 Million

Others Institutions Holding PRLD

# of Institutions

Shares Held

30.4M

Call Options Held

6.4K

Put Options Held

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $31.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account